153 related articles for article (PubMed ID: 35003892)
1. SARS-CoV-2 causes a significant stress response mediated by small RNAs in the blood of COVID-19 patients.
Liu X; Wen YZ; Huang ZL; Shen X; Wang JH; Luo YH; Chen WX; Lun ZR; Li HB; Qu LH; Shan H; Zheng LL
Mol Ther Nucleic Acids; 2022 Mar; 27():751-762. PubMed ID: 35003892
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 remodels the landscape of small non-coding RNAs with infection time and symptom severity.
Corell-Sierra J; Marquez-Molins J; Marqués MC; Hernandez-Azurdia AG; Montagud-Martínez R; Cebriá-Mendoza M; Cuevas JM; Albert E; Navarro D; Rodrigo G; Gómez G
NPJ Syst Biol Appl; 2024 Apr; 10(1):41. PubMed ID: 38632240
[TBL] [Abstract][Full Text] [Related]
3. Changes of Small Non-coding RNAs by Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Wu W; Choi EJ; Wang B; Zhang K; Adam A; Huang G; Tunkle L; Huang P; Goru R; Imirowicz I; Henry L; Lee I; Dong J; Wang T; Bao X
Front Mol Biosci; 2022; 9():821137. PubMed ID: 35281271
[TBL] [Abstract][Full Text] [Related]
4. Changes of small non-coding RNAs by severe acute respiratory syndrome coronavirus 2 infection.
Wu W; Choi EJ; Wang B; Zhang K; Adam A; Huang G; Tunkle L; Huang P; Goru R; Imirowicz I; Henry L; Lee I; Dong J; Wang T; Bao X
bioRxiv; 2021 Dec; ():. PubMed ID: 34981063
[TBL] [Abstract][Full Text] [Related]
5. In silico approach for the identification of tRNA-derived small non-coding RNAs in SARS-CoV infection.
Ajmeriya S; Bharti DR; Kumar A; Rana S; Singh H; Karmakar S
J Appl Genet; 2024 May; 65(2):403-413. PubMed ID: 38514586
[TBL] [Abstract][Full Text] [Related]
6. microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary.
Lukiw WJ
Noncoding RNA; 2021 Jun; 7(2):. PubMed ID: 34207055
[TBL] [Abstract][Full Text] [Related]
7. Global survey of miRNAs and tRNA-derived small RNAs from the human parasitic protist Trichomonas vaginalis.
Wang ZS; Zhou HC; Wei CY; Wang ZH; Hao X; Zhang LH; Li JZ; Wang ZL; Wang H
Parasit Vectors; 2021 Jan; 14(1):87. PubMed ID: 33514387
[TBL] [Abstract][Full Text] [Related]
8. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
9. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
10. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
11. microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review.
Maranini B; Ciancio G; Ferracin M; Cultrera R; Negrini M; Sabbioni S; Govoni M
Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207576
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus.
Li S; Liu W; Chen Y; Wang L; An W; An X; Song L; Tong Y; Fan H; Lu C
Brief Bioinform; 2021 Mar; 22(2):1378-1386. PubMed ID: 33423067
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
14. The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review.
Rizkita LD; Astuti I
J Pharm Anal; 2021 Jun; 11(3):265-271. PubMed ID: 33782640
[TBL] [Abstract][Full Text] [Related]
15. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
Vishnubalaji R; Shaath H; Alajez NM
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
[TBL] [Abstract][Full Text] [Related]
16. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.
Park JH; Choi Y; Lim CW; Park JM; Yu SH; Kim Y; Han HJ; Kim CH; Song YS; Kim C; Yu SR; Oh EY; Lee SM; Moon J
Cells; 2021 Sep; 10(9):. PubMed ID: 34572043
[TBL] [Abstract][Full Text] [Related]
17. The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection.
Lin Y; Sun Q; Zhang B; Zhao W; Shen C
Front Cell Dev Biol; 2023; 11():1229393. PubMed ID: 37576600
[TBL] [Abstract][Full Text] [Related]
18. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.
Merino GA; Raad J; Bugnon LA; Yones C; Kamenetzky L; Claus J; Ariel F; Milone DH; Stegmayer G
Bioinformatics; 2021 Apr; 36(24):5571-5581. PubMed ID: 33244583
[TBL] [Abstract][Full Text] [Related]
19. The PERK/PKR-eIF2α Pathway Negatively Regulates Porcine Hemagglutinating Encephalomyelitis Virus Replication by Attenuating Global Protein Translation and Facilitating Stress Granule Formation.
Shi J; Li Z; Xu R; Zhang J; Zhou Q; Gao R; Lu H; Lan Y; Zhao K; He H; Gao F; He W
J Virol; 2022 Jan; 96(1):e0169521. PubMed ID: 34643429
[TBL] [Abstract][Full Text] [Related]
20. ER Stress in COVID-19 and Parkinson's Disease: In Vitro and In Silico Evidences.
Chaudhry ZL; Gamal M; Ferhati I; Warda M; Ahmed BY
Brain Sci; 2022 Apr; 12(4):. PubMed ID: 35448038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
